(Q63836844)

English

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

clinical trial

Statements

PETEY (English)
0 references
A Randomized, Phase 2 Study of Single-agent Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma (English)
0 references
0 references
0 references
September 2010
0 references
November 2012
0 references
25
0 references
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit